JP2023529216A5 - - Google Patents

Info

Publication number
JP2023529216A5
JP2023529216A5 JP2022575988A JP2022575988A JP2023529216A5 JP 2023529216 A5 JP2023529216 A5 JP 2023529216A5 JP 2022575988 A JP2022575988 A JP 2022575988A JP 2022575988 A JP2022575988 A JP 2022575988A JP 2023529216 A5 JP2023529216 A5 JP 2023529216A5
Authority
JP
Japan
Prior art keywords
groups
linear
branched
independently
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022575988A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023529216A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/036944 external-priority patent/WO2021252849A1/en
Publication of JP2023529216A publication Critical patent/JP2023529216A/ja
Publication of JP2023529216A5 publication Critical patent/JP2023529216A5/ja
Pending legal-status Critical Current

Links

JP2022575988A 2020-06-12 2021-06-11 Apol1の阻害剤及びその使用 Pending JP2023529216A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063038276P 2020-06-12 2020-06-12
US63/038,276 2020-06-12
PCT/US2021/036944 WO2021252849A1 (en) 2020-06-12 2021-06-11 Inhibitors of apol1 and use of the same

Publications (2)

Publication Number Publication Date
JP2023529216A JP2023529216A (ja) 2023-07-07
JP2023529216A5 true JP2023529216A5 (cg-RX-API-DMAC7.html) 2024-06-17

Family

ID=76797122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022575988A Pending JP2023529216A (ja) 2020-06-12 2021-06-11 Apol1の阻害剤及びその使用

Country Status (7)

Country Link
US (1) US20230014907A1 (cg-RX-API-DMAC7.html)
EP (1) EP4165023A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023529216A (cg-RX-API-DMAC7.html)
CN (1) CN115867532A (cg-RX-API-DMAC7.html)
AU (1) AU2021286666A1 (cg-RX-API-DMAC7.html)
CA (1) CA3185144A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021252849A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3897833T (lt) 2018-12-17 2026-04-27 Vertex Pharmaceuticals Incorporated Apol1 inhibitoriai ir jų panaudojimo būdai
EP4097083A1 (en) 2020-01-29 2022-12-07 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same
EP4114385A1 (en) 2020-03-06 2023-01-11 Vertex Pharmaceuticals Incorporated Methods of treating apol-1 dependent focal segmental glomerulosclerosis
EP4146633A4 (en) 2020-05-07 2024-09-25 Rambam Med-Tech Ltd. COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1
JP2023530271A (ja) 2020-06-12 2023-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Apol1の阻害剤及びこれを使用する方法
CN115867543A (zh) 2020-06-12 2023-03-28 弗特克斯药品有限公司 Apol1抑制剂的固体形式及其使用方法
BR112023003423A2 (pt) 2020-08-26 2023-03-21 Vertex Pharma Inibidores de apol1 e métodos de uso destes
US12612379B2 (en) 2021-11-30 2026-04-28 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
CA3244229A1 (en) * 2021-12-24 2023-06-29 Psylo Pty Ltd COMPOUNDS
MX2024008868A (es) 2022-01-18 2024-09-23 Maze Therapeutics Inc Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso.
WO2023154314A1 (en) * 2022-02-08 2023-08-17 Vertex Pharmaceuticals Incorporated Spiro piperidine derivatives as inhibitors of apol1 and methods of using same
EP4476228A1 (en) * 2022-02-08 2024-12-18 Vertex Pharmaceuticals Incorporated 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same
EP4476199A1 (en) * 2022-02-08 2024-12-18 Vertex Pharmaceuticals Incorporated 2-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using same
WO2024220852A2 (en) * 2023-04-20 2024-10-24 University Of Florida Research Foundation, Incorporated Tead core inhibitors for cancer therapeutics
EP4705296A1 (en) * 2023-05-03 2026-03-11 OmniAB, Inc. Heteroarylindole inhibitors of apol-1
CN116789603A (zh) * 2023-06-06 2023-09-22 南昌大学 一种新型多菌灵半抗原、全抗原、抗体及其制备方法及应用
WO2025042797A1 (en) * 2023-08-18 2025-02-27 Shattuck Labs, Inc. Trim7 inhibitors and uses thereof
GB202401326D0 (en) * 2024-02-01 2024-03-20 Podium Bio Ltd Novel compounds
WO2025231011A1 (en) * 2024-05-01 2025-11-06 Omniab, Inc. Heteroarylindole inhibitors of apol-1
TW202613098A (zh) * 2024-07-09 2026-04-01 大陸商上海旭成醫藥科技有限公司 一種APOLs抑制劑

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
EP0924209B1 (en) * 1997-12-19 2003-05-02 Eli Lilly And Company Hypoglycemic imidazoline compounds
GB9905010D0 (en) * 1999-03-04 1999-04-28 Merck Sharp & Dohme Therapeutic agents
FR2801585B1 (fr) * 1999-11-25 2002-02-15 Fournier Ind & Sante Nouveaux antagonistes des recepteurs de l'ii-8
GB0003397D0 (en) * 2000-02-14 2000-04-05 Merck Sharp & Dohme Therapeutic agents
WO2002028831A1 (en) * 2000-10-02 2002-04-11 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
FR2824827B1 (fr) * 2001-05-17 2004-02-13 Fournier Lab Sa Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
FR2824826B1 (fr) * 2001-05-17 2003-11-07 Fournier Lab Sa Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
WO2007061763A2 (en) * 2005-11-22 2007-05-31 Merck & Co., Inc. Indole orexin receptor antagonists
JP5107589B2 (ja) * 2007-02-13 2012-12-26 旭化成株式会社 インドール誘導体
EP2178870B1 (en) * 2007-08-17 2018-09-19 LG Chem, Ltd. Indole and indazole compounds as an inhibitor of cellular necrosis
WO2016029310A1 (en) * 2014-08-27 2016-03-03 The Governing Council Of The University Of Toronto Cannabinoid type 1 receptor modulators
LT3897833T (lt) * 2018-12-17 2026-04-27 Vertex Pharmaceuticals Incorporated Apol1 inhibitoriai ir jų panaudojimo būdai
EP4097083A1 (en) * 2020-01-29 2022-12-07 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same

Similar Documents

Publication Publication Date Title
JP2023530271A5 (cg-RX-API-DMAC7.html)
JP2025505200A5 (cg-RX-API-DMAC7.html)
JP2023512213A5 (cg-RX-API-DMAC7.html)
IL286839B (en) Propyne-indole compounds
JP4871257B2 (ja) 2−フェニルプロピオン酸誘導体およびそれらを含有する医薬組成物
KR970701698A (ko) 프로스타글란딘 i₂작용물질로서의 나프탈렌 유도체(naphthalene derivatives as prostaglandin i₂agonists)
US6753333B2 (en) Chiral fluoroquinolone arginine salt forms
DE69010232D1 (de) 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
EA017806B1 (ru) Антимикробные соединения, их синтез и применение для лечения инфекций у млекопитающих
RU2008146751A (ru) Новые производные имидазола, их получение и использование в качестве лекартвенных средств
US20110257233A1 (en) Benzoisothiazolones as inhibitors of phosphomannose isomerase
KR101422299B1 (ko) (2r)-2-〔(4-설포닐)아미노페닐〕프로판아마이드 및 이들 화합물을 함유하는 약학 조성물
EP1311506B1 (en) Chiral fluoroquinolizinone arginine salt forms
JPWO2001036402A1 (ja) 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
EP1080081A1 (en) Benzofuroxan derivatives and their use in treating angina pectoris
KR910004559A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체
US20050261301A1 (en) Therapeutic ion channel blocking agents and methods of use thereof
RU2004117548A (ru) Амиды антраниловой кислоты и их применение в фармацевтике
MA27492A1 (fr) Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
CA2123101C (en) Nitroxyalkylamide derivative
US8815847B2 (en) [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
MA27545A1 (fr) Nouveaux dérivés de benzothiadiazines fluorées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA2479341A1 (en) Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
RU2006113947A (ru) Амидины и их производные и содержащие их фармацевтические композиции
EP1948172A1 (en) Diaryl ureas for treating diabetic neuropathy